Reduced inhibition of endothelial-derived relaxing factor causes the hyperdynamic circulation in chronic severe anemia.

[1]  P. Poole‐Wilson,et al.  Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. , 1993, British heart journal.

[2]  P. Poole‐Wilson,et al.  Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery , 1992, Circulation.

[3]  P. Poole‐Wilson,et al.  Pathogenesis of Edema in Constrictive Pericarditis: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones Before and After Pericardiectomy , 1991, Circulation.

[4]  S. Moncada,et al.  Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. , 1991, The Journal of clinical investigation.

[5]  S. Moncada,et al.  Hyperdynamic circulation in cirrhosis: a role for nitric oxide? , 1991, The Lancet.

[6]  S. Moncada,et al.  Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats , 1990, British journal of pharmacology.

[7]  T. Lüscher,et al.  Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. , 1990, Circulation.

[8]  S. Moncada,et al.  Control of regional blood flow by endothelium-derived nitric oxide. , 1990, Hypertension.

[9]  R. Busse,et al.  EDRF Increases Cyclic GMP in Platelets During Passage Through the Coronary Vascular Bed , 1989, Circulation research.

[10]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[11]  P A Poole-Wilson,et al.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. , 1989, Circulation.

[12]  S Moncada,et al.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. , 1989, Biochemical pharmacology.

[13]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  O. Griffith,et al.  NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? , 1989, Biochemical and biophysical research communications.

[15]  J. Gillespie,et al.  Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non‐vascular smooth muscle , 1988, British journal of pharmacology.

[16]  V. Miller,et al.  Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. , 1988, The American journal of physiology.

[17]  P. Harris.  ROLE OF ARTERIAL PRESSURE IN THE OEDEMA OF HEART DISEASE , 1988, The Lancet.

[18]  D. Edwards,et al.  EDRF coordinates the behaviour of vascular resistance vessels , 1987, Nature.

[19]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[20]  W. Martin,et al.  The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor , 1986, British journal of pharmacology.

[21]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[22]  F. Florenzano,et al.  Left ventricular function in chronic anemia: evidence of noncatecholamine positive inotropic factor in the serum. , 1984, The American journal of cardiology.

[23]  R. Kagi,et al.  1,8-Dimethylnaphthalene as an indicator of petroleum maturity , 1984, Nature.

[24]  K. Tanaka,et al.  Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.

[25]  W. Shoemaker,et al.  Hemoglobin solution in the treatment of hemorrhagic shock , 1982, Critical care medicine.

[26]  W. Shoemaker,et al.  Comparison of cardiorespiratory effects of crystalline hemoglobin, whole blood, albumin, and Ringer's lactate in the resuscitation of hemorrhagic shock in dogs. , 1978, Surgery.

[27]  J. Weinberg,et al.  Endocytosis of red blood cells or haemoglobin by activated macrophages inhibits their tumoricidal effect , 1977, Nature.

[28]  N. Fowler,et al.  Blood viscosity and cardiac output in acute experimental anemia. , 1975, Journal of applied physiology.

[29]  R. Adolph,et al.  Cardiovascular effects of anemia. , 1972, American heart journal.

[30]  H. Rodriguez.  CÆSAREAN SECTION UNDER LOCAL ANÆSTHESIA , 1970 .

[31]  W. Abelmann,et al.  The Hemodynamic Response to Chronic Anemia , 1969, Circulation.

[32]  J. Murray,et al.  Ventricular performance in acute normovolemic anemia and effects of beta blockade. , 1966, The American journal of physiology.

[33]  S. Roy,et al.  Hemodynamic Effects of Chronic Severe Anemia , 1963, Circulation.

[34]  R. L. Parsons,et al.  A correlation of clinical and hemodynamic studies in patients with mild and severe anemia with and without congestive failure. , 1963, Annals of internal medicine.

[35]  V. Sharma,et al.  MECHANISM OF ŒDEMA IN CHRONIC SEVERE ANÆMIA , 1963, British heart journal.

[36]  F. Reubi,et al.  The renal extraction of sodium paraaminohippurate (PAH) in anaemic subjects before and after a red cell transfusion. , 1962, Clinical science.

[37]  F. Roughton,et al.  The kinetics and equilibria of the reactions of nitric oxide with sheep haemoglobin , 1957, The Journal of physiology.

[38]  Carter Vb,et al.  The power of words. , 1951, Lancet.

[39]  S. Bradley,et al.  Renal function during chronic anemia in man. , 1947, Blood.

[40]  A. Cowley,et al.  Long-term control of arterial blood pressure. , 1992, Physiological reviews.

[41]  R. Busse,et al.  Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. , 1992, Circulation research.

[42]  J. Angus,et al.  Endothelium-derived relaxing factor. , 1989, Pharmacology & therapeutics.

[43]  W. Lockette,et al.  Vascular relaxation and cGMP in hypertension. , 1988, The American journal of physiology.

[44]  U. Förstermann.  Properties and mechanisms of production and action of endothelium-derived relaxing factor. , 1986, Journal of cardiovascular pharmacology.

[45]  F. Murad,et al.  Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. , 1978, Advances in cyclic nucleotide research.

[46]  R. Lodato,et al.  hypotension: Implications for the involvement of nitric oxide , 2022 .